Frankfurt am Main, Germany

Lothar Schwink

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc., Sanofi. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lothar Schwink. Retrieved from https://idiyas.com/inventor/lothar-schwink-tejjhkj4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

Average Co-Inventor Count = 28.0


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lothar Schwink: Innovator in Macrocyclic Compounds

Introduction

Lothar Schwink is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Lothar Schwink holds a patent for "Macrocyclic compounds, compositions, and methods of using thereof." This patent includes CFTR modulators, pharmaceutical compositions, and methods of making and using these compounds. His innovative approach in this area highlights the potential for new treatments in the pharmaceutical industry.

Career Highlights

Throughout his career, Lothar has worked with prominent companies such as Genzyme Corporation and Sionna Therapeutics Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of pharmaceuticals.

Collaborations

Lothar Schwink has collaborated with various professionals in his field, including his coworker John E. Macor. These collaborations have fostered an environment of innovation and have led to advancements in their shared areas of expertise.

Conclusion

Lothar Schwink's contributions to the field of macrocyclic compounds and his collaborations with industry leaders underscore his role as a significant inventor. His work continues to influence the pharmaceutical landscape, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…